T Cell Receptor CDR2β and CDR3β Loops Collaborate Functionally to Shape the iNKT Cell Repertoire  by Mallevaey, Thierry et al.
Immunity
ArticleT Cell Receptor CDR2b and CDR3b Loops Collaborate
Functionally to Shape the iNKT Cell Repertoire
Thierry Mallevaey,1 James P. Scott-Browne,1 Jennifer L. Matsuda,1 Mary H. Young,1 Daniel G. Pellicci,7 Onisha Patel,8
Meena Thakur,6 Lars Kjer-Nielsen,7 Stewart K. Richardson,6 Vincenzo Cerundolo,5 Amy R. Howell,6 James McCluskey,7
Dale I. Godfrey,7 Jamie Rossjohn,8 Philippa Marrack,1,2,3,4 and Laurent Gapin1,*
1Department of Immunology, University of Colorado Denver and National Jewish Health, Denver, CO 80206, USA
2Howard Hughes Medical Institute
3Departments of Medicine
4Biochemistry and Molecular Genetics
University of Colorado Denver School of Medicine, Denver, CO 80220, USA
5Tumour Immunology Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, UK
6Department of Chemistry, University of Connecticut, Storrs, CT 06269, USA
7Department of Microbiology & Immunology, University of Melbourne, Parkville, Victoria 3010, Australia
8The Protein Crystallography Unit, ARC Centre of Excellence in Structural and Functional Microbial Genomics,
Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, Victoria 3800, Australia
*Correspondence: gapinl@njhealth.org
DOI 10.1016/j.immuni.2009.05.010SUMMARY
Mouse type I natural killer T cell receptors (iNKTTCRs)
use a single Va14-Ja18 sequence and Vbs that are
almost always Vb8.2, Vb7, or Vb2, although the basis
of this differential usage is unclear. We showed that
the Vb bias occurred as a consequence of the
CDR2b loops determining the affinity of the iNKT
TCR for CD1d-glycolipids, thus controlling positive
selection. Within a conserved iNKT-TCR-CD1d dock-
ing framework, these inherent Vb-CD1d affinities are
further modulated by the hypervariable CDR3b loop,
thereby defining a functional interplay between the
two iNKT TCRCDRb loops. These Vb biases revealed
abroadlyhierarchical response inwhichVb8.2>Vb7>
Vb2 in the recognition of diverse CD1d ligands. This
restriction of the iNKT TCR repertoire during thymic
selection paradoxically ensures that each peripheral
iNKT cell recognizes a similar spectrum of antigens.
INTRODUCTION
T lymphocyte recognition of antigen via their somatically rear-
ranged ab T cell receptors (TCRs) is central to the proper
functioning of the immune system. The molecular basis for the
recognitionofantigenicpeptidesbound tomajorhistocompatibility
complex (MHC) molecules by ab TCRs has been characterized.
Although some variability of the TCR docking modes onto the
pMHC surfaces has been observed, a rough docking mode
between the TCR-pMHC appears preserved, in which the Va and
Vb domains are positioned over the a2-helix and a1-helix, respec-
tively (Rudolph et al., 2006). Recent findings suggest that such
a mode of recognition might be the result of structural constraints
within the TCR and MHCmolecules selected through coevolution
of genes encoding for these molecules (Feng et al., 2007; Garcia
et al., 2009; Marrack et al., 2008; Scott-Browne et al., 2009).60 Immunity 31, 60–71, July 17, 2009 ª2009 Elsevier Inc.A sizeable portion of ab TCR+ T cells does not recognize
peptide antigens presented by conventional polymorphic MHC
I and MHC II molecules. ab TCRs have been described that
recognize lipid or glycolipid antigens presented by members of
the monomorphic lipid-binding family of molecules, CD1 (Brigl
and Brenner, 2004). The most extensively studied lipid-reactive
T cells are natural killer T (NKT) cells, which recognize a number
of glycolipid antigens in association with CD1d. Two broad
classes of NKT cells have been defined on the basis of TCR
expression and antigen reactivity (Godfrey et al., 2004). Most
studies of these cells focus on type I, or iNKT cells, which are
the most prevalent NKT cells in mice (Matsuda et al., 2008).
These iNKT cells express a TCR that is the product of a canonical
rearrangement between the Va14 gene segment (Va24 in
human) and the Ja18 gene segment, with a CDR3a region
invariant at the amino acid level (Koseki et al., 1990; Lantz and
Bendelac, 1994). This Va14 invariant chain is coexpressed with
a limited set of Vb chains, predominantly Vb8.2, Vb7, and Vb2
in mice and Vb11 in humans (Dellabona et al., 1994; Lantz and
Bendelac, 1994; Porcelli et al., 1993). However, unlike their
TCRa chain, these Vb chains are highly diverse in both their
CDR3 composition and association with Jb segments (Behar
et al., 1999; Lantz and Bendelac, 1994; Matsuda et al., 2001)
and the basis for this diversity is unclear. iNKT cells recognize
several microbe-derived glycosphingolipid (Kinjo et al., 2005;
Mattner et al., 2005) and diacylglycerol antigens (Kinjo et al.,
2006), including the prototypical glycosphingolipid antigen
a-galactosylceramide (aGC) (Kawano et al., 1997), and are
best identified with the CD1d tetramer loaded with this antigen
(Benlagha et al., 2000; Matsuda et al., 2000).
Upon TCR engagement, iNKT cells rapidly release large
amounts of cytokines and chemokines that can enhance or
suppress immune responses. As such, iNKT cells have been
shown to influence a broad range of diseases, including cancer,
autoimmunity, allergy, and infection (Bendelac et al., 2007;
Kronenberg, 2005). Identification of the molecular features of
iNKT TCR receptor-antigen recognition and the mechanisms
responsible for the formation of the iNKT cell repertoire are of
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these cells.
Recent crystallographic and mutational analyses have shown
how the iNKT TCR recognizes glycolipid-CD1d complexes. The
crystal structure of iNKT TCRs, unliganded (Gadola et al., 2006;
Kjer-Nielsen et al., 2006; Zajonc et al., 2008), and in complex
with aGC-CD1d revealed a unique docking strategy that differs
from most TCR-MHC-peptide interactions (Borg et al., 2007;
Pellicci et al., 2009).Namely, the iNKTTCRdockedat theextreme
end of, and parallel to, the aGC-CD1d complex. Here, theCDR1a
and CDR3a loops of the invariant TCRa chain dominated the
interaction with the antigen and aGC-CD1d, respectively,
whereas the role of the TCRb chain was restricted to the
CDR2b loop interacting with CD1d. CDR3b, the only ‘‘nongerm-
line-encoded’’ region of the iNKT TCR, does not make contact
with the antigen but instead is positioned over the a2 helix of
CD1d. Thus, recognition of aGC-CD1d by the iNKT TCR seems
to be entirely mediated by the germline-encoded surface of the
iNKT TCR. Extensive mutational analyses of both mouse and
human iNKT TCRs (Scott-Browne et al., 2007; Wun et al., 2008)
revealed that an energetic ‘‘hot spot’’ was formed by residues
within the CDR1a, CDR3a, and CDR2b loops of the NKT TCR
that were critical for the recognition of the aGC-CD1d complex
and provided a snapshot into the basis of iNKT cell recognition.
The mechanisms that drive the Vb bias of in the iNKT cell
repertoire remain unclear. Moreover, it is not known whether
different TCRb chains might allow the iNKT TCR to change its
specificity for different antigens. Several scenarios, including
possible pairing preferences with the invariant NKT TCRa chain
(Degermann et al., 1999; Gui et al., 2001) and/or influence of
thymic selection during development (Schumann et al., 2006;
Wei et al., 2006), have been proposed to explain the Vb bias.
Here, we demonstrate that specific sequences within the
CDR2b and CDR3b loops are responsible for shaping the iNKT
cell repertoire in vivo, and do so by constraining iNKT TCR inter-
action with antigen(s)-CD1d complexes.
RESULTS
Vb Chains Confer Differential Affinity for CD1d
The TCRb repertoire of mouse iNKT cells is biased, with prefer-
ential usage of Vb8, Vb7, and Vb2 segments. Such a bias has
been proposed to result, at least partly, from poor pairing
between the Va14 invariant chain and certain Vb chains (Gui
et al., 2001). To rigorously test whether pairing constraints can
contribute to the observed bias in the repertoire, we co-ex-
pressed the Va14 invariant chain with each of the Vb chains in
an ab TCR hybridoma (White et al., 1993). We first transduced
the hybridoma with a murine stem cell virus (MSCV)-based
retrovirus encoding the Va14 invariant chain and green fluores-
cent protein (GFP) and selected the cells on the basis of GFP
expression. Next, we cloned each of the 20 different mouse Vb
chains in the context of the same CDR3b rearrangement (i.e.,
the CDR3b and Jb) from the DO-11.10 TCRb chain into another
MSCV-based retroviral plasmid and transduced the Va14-ex-
pressing hybridoma separately with each of the TCRb chains.
Transduced hybridomas were sorted for cell-surface expression
of the TCR and tested for their interaction with the aGC-CD1d
tetramer. Under these conditions, all of the individual TCRbchains paired with the Va14 chain and all the hybridomas
expressed TCRmolecules on their cell surface (Figure 1A). Some
variability in TCR expression between the various Vb chains was
observed that might be related to the efficiency of transduction
between experiments. Nevertheless, these results suggested
that all Vb chains can pair with the Va14 invariant chain.
TCRs containing Vb8.2, Vb8.1, Vb8.3, Vb7, and Vb2 stained
intensely with aGC-CD1d tetramer, whereas Vb9-, Vb10-, and
Vb14-containing TCRs bound the aGC-CD1d tetramer weakly.
TCRs containing the other Vb chains did not stain above back-
ground (Figure 1A). Comparison of tetramer staining intensity
relative to TCR expression and staining experiments that use
a wide range of aGC-CD1d tetramer concentrations revealed
different relative avidities for the aGC-CD1d complex as a func-
tion of the Vb chain usage, with the hierarchy Vb8.2 > Vb8.1 R
Vb7 > Vb8.3R Vb2 > Vb9R Vb14R Vb10 (Figures 1B and 1C).
Because CD4 expression by the original TCRab parent
hybridoma is heterogeneous, we generated two sets of hybrid-
omas expressing the same panel of TCRs with or without CD4
expression. The Vb hierarchy of the relative avidity of the various
TCRs for the aGC-CD1d complex remained the same irres-
pective of CD4 expression on the surface of the hybridoma,
with the exception of the Vb14-containing TCR (Figure S1A avail-
able online). Transduction of the double-negative (CD4CD8)
hybridoma DN32.D3 (Lantz and Bendelac, 1994) with a mouse
CD4-encoding retrovirus also did not alter the binding of the
TCR to the aGC-CD1d complex (Figure S1B), suggesting that
CD4 only plays a minor role, if any, in modulating the affinity of
the iNKT TCR for the aGC-CD1d complex.
To analyze the natural Vb chain repertoire expressed by the
iNKT cell population, we sorted aGC-CD1d tetramer+ TCRb+ cells
from the thymus of C57BL/6 mice and expanded the cells in the
presence of IL-15 (Matsuda et al., 2002). After 4 days of culture,
the cells were stained with a panel of VbmAbs and the repertoire
wasanalyzedbyflowcytometry.Thisstrategyallowed for theanal-
ysis of a large number of pure iNKTcells (Figure 1D) andprevented
any potential competition for binding that might occur during cos-
tainingwith theaGC-CD1d tetramerandcertainVbmAbs (datanot
shown). The prevalence of the various Vb chains analyzed in the
ex vivo iNKT cell repertoire correlated positively with the relative
apparent avidity for the aGC-CD1d tetramer conferred to the
TCR by the usage of these various Vb chains (Figure 1D). For
example, an iNKT TCR containing Vb8.2 binds aGC-CD1d
tetramer the best and Vb8.2 was the Vb most frequently used by
iNKTcells.Conversely, iNKTTCRs includingVb9bind the tetramer
poorly and this Vb is rarely used by iNKT cells.
Together, these data demonstrate that the iNKT TCRa chain
can pair with all Vb segments. The results also show that the
differential Vb usage in the iNKT TCR affects its apparent affinity
for aGC-CD1d. Furthermore, the hierarchywith which Vbs confer
ligand affinity on the iNKT TCRs correlates with the frequency
with which these Vbs are used in iNKT TCRs in vivo. This
suggests that Vbs might affect recognition of a-GC-CD1d and
endogenous positively selecting ligand(s) similarly.
Clustering of Vb-Containing iNKT TCRs According
to Antigen Stimulation
Because different Vb usage in the iNKT TCR has been suggested
to influence antigen specificity, we next tested how our panel ofImmunity 31, 60–71, July 17, 2009 ª2009 Elsevier Inc. 61
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(A) Staining of hybridomas expressing the Va14i TCRa chain or Va13-Ja18 TCRa chain (negative controls), paired with the indicated Vb chains in the context of
a unique CDR3b.
(B) The MFI of aGC-CD1d tetramer staining for each hybridoma was determined for a narrow TCR gate. Data represent the mean + SEM of three independent
experiments.
(C) The indicated hybridomas were stained with increasing concentrations of aGC-CD1d tetramer. TheMFI of tetramer staining was determined for a narrow TCR
gate. The data represent the mean of two independent experiments.
(D) Ex vivo sorted NKT cells were stained with specific Vb antibodies. Data represent a plot of the relative Vb usage (x axis) against the aGC-CD1d tetramer MFI of
the appropriate Vb-expressing hybridomas as determined in (B) (y axis). Data represent the mean ± SEM of two independent experiments.hybridomas responded to ten structurally different antigens
known to stimulate iNKT cells when presented by CD1d mole-
cules, including the self glycosphingolipid iGb3 (Zhou et al.,
2004), the microbial a-glycosphingolipid (GSL-1’) (Kinjo et al.,
2005; Mattner et al., 2005), and several nonglycosidic
compounds (Silk et al., 2008). Hybridomas expressing Vb8.2,
Vb8.1, Vb7, and Vb8.3- containing iNKT TCRs responded to all
the antigens tested (Figure 2A), whereas hybridomas expressing
Vb2 responded only to PBS57, aGC, GSL-1’, ThrCer, AraCer,
GlyCer, and iGb3, but not to 30- and 40 hydroxyl variants of
aGC (3 dOH aGC and 4 dOH aGC) nor to a-glucosylceramide
(aGluCer). Vb9-expressing hybridomas responded to a limited
number of antigens (PBS57, aGC, and GSL-1’), whereas the
response of Vb10- and Vb14-containing iNKT TCRs was further
restricted to the synthetic analog PBS57 (Liu et al., 2006) only62 Immunity 31, 60–71, July 17, 2009 ª2009 Elsevier Inc.(Figure 2A). Hybridomas expressing the other Vb chains did
not respond to any antigen used in this study, although they
were equally responsive to anti-CD3 stimulation (data not
shown). These results indicate that the response of the iNKT
cell hybridomas is not randomly distributed, but instead varies
as a function of the Vb usage. By rearranging the strength of
the response versus the number of hybridomas stimulated
by a given antigen, we found that Vb segment usage correlated
with the relative ‘‘potency’’ of the stimulating antigen (Figure
2B). Although hybridomas expressing iNKTTCRswith a relatively
high affinity for aGC-CD1d, such as those containing Vb8s and
Vb7 chains, responded to all antigens, hybridomas with iNKT
TCRs of apparently lower affinity for aGC-CD1d responded
only to the most potent antigens. These results suggest that
the relative apparent avidity of the iNKT TCR for a given
Immunity
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used.
Mutational Analysis of Vb8.2-, Vb7-, or Vb2-Containing
iNKT TCRs
To test whether the underlying energetic basis of the iNKT TCR
aGC-CD1d complex interaction might change as a function of
the Vb chain in the TCR, we compared the role of individual
CDR1a, CDR2a, and CDR3a residues in the Va14 invariant chain
when paired with wild-type Vb8.2, Vb7, or Vb2 chains. Our
results demonstrated that the same residues within the CDR1a
(P28a, N30a) and CDR3a (D93a, R94a, G95a, S96a, L98a) loops
were important for the recognition of the aGC-CD1d complex,
irrespective of the Vb chain associated with the Va14 invariant
chain (Figures 3A–3C). These results suggest that the docking
of the Va14 domain within Vb8.2, Vb7, and Vb2-containing
iNKT TCRs on the aGC-CD1d-glycolipid complex is similar,
and such a conclusion is supported by the Vb8.2- and Vb7-con-
taining iNKT TCRs in complex with aGC presented by mouse
CD1d molecules (Pellicci et al., 2009).
Our previous mutational analysis of a Vb8.2-containing iNKT
TCR identified several CDR2b residues (Y46b, Y48b, and to
some extent E54b) required for the recognition of the antigen-
CD1d complex (Scott-Browne et al., 2007). Alanine substitutions
of these residues revealed that although only a few contacts are
mediated via the Vb domain, they are absolutely critical to the
interaction. These residues are identical, or similar, between
human Vb11 and mouse Vb8 s (Figure S2). However, the CDR1
or CDR2b regions of mouse Vb2 and Vb7 are unexpectedly
dissimilar from those of Vb8 s. To understand further the molec-
ular basis for the restricted TCRb repertoire, we mutated indi-
vidual residues in the CDR1b and CDR2b loops to alanine in
Vb7 and Vb2 chains and expressed each mutant with the wild-
type Va14 partner in TCR-deficient hybridomas. We then
Figure 2. Clustering of Vb-Containing iNKT
TCRs According to Antigen Stimulation
(A and B) Enzyme-linked immunosorbent assay of IL-2
production by hybridomas expressing iNKT TCRs
containing Vb1 to Vb20 TCRb chains, stimulated
with mCD1d-expressing A20 cells in the presence of
PBS57 (1 mg/ml), aGC (1 mg/ml), GSL-1’ (1 mg/ml),
ThrCer (0.2 mg/ml), AraCer (0.2 mg/ml), GlyCer
(0.2 mg/ml), iGb3 (10 mg/ml), 3 dOH aGC (1 mg/ml),
4 dOH aGC (1 mg/ml), and a-GluCer (1 mg/ml).
(B) Rearrangement of the strength of the response
versus the number of hybridomas stimulated. Data
represent the mean of two (for ThrCer, AraCer, and
GlyCer) and four (for PBS57, aGC, GSL-1’, iGb3,
3 dOH aGC, 4 dOH aGC, and aGluCer) independent
experiments.
analyzed the influence of each substitution
on the recognition of CD1d tetramers loaded
with aGC (Figures 3D–3F). For the Vb7 chain,
alanine substitutions in CDR1b did not
substantially affect aGC-CD1d tetramer
binding. In contrast, tetramer binding was
completely abrogated for the bY48A substi-
tution and reduced by 70% for bI46A,
bS47A, bN53A, and bS54Amutations. bD49A and bS52A substi-
tutions enhanced tetramer binding (Figure 3E). In the Vb2 TCRb
CDR2 region, bR48A and bE54A substitutions reduced the
tetramer binding by 50% and 80%, respectively, whereas other
substitutions in CDR2b did not affect, or even enhanced, aGC-
CD1d tetramer binding (Figure 3F). CDR1b alanine mutants
bound the aGC-CD1d tetramer equivalently to their wild-type
counterpart, with the exception of bY28A that almost completely
abrogated tetramer binding and bW30A that reduced the binding
by 70% (Figure 3F), which suggest a potential involvement of the
CDR1b loop in mediating recognition with CD1d.
The fact that similar residues, located at the same positions,
between Vb8.2 and Vb7 (CDR2b 46, 48, and 54) are required for
recognition of the aGC-CD1d complex suggested that Vb8.2
and Vb7 make similar contacts on CD1d-glycolipid complexes,
consistent with crystallographic data (Pellicci et al., 2009). Curi-
ously, although Vb2 also requires positions R48b and E54b to
bind aGC-CD1d complexes, there is an increased effect of
CDR1b mutations compared to Vb8.2 and Vb7, suggesting that
Vb2 might dock slightly differently on CD1d.
CDR2b Dictates iNKT TCR Interactions
with mCD1d + Foreign or Self Ligands
The in vitro experiments described above highlighted the impor-
tance of CDR2b residues in aGC-CD1d recognition, raising the
possibility that the Vb bias of the iNKT cell repertoire might
depend on the ability of particular CDR2b residues to make
CD1d contacts in the context of the interaction determined by
the canonical TCRa chain. To assess directly whether the
CDR2b loop influences the development of iNKT cells, we
produced TCRb ‘‘retrogenic’’ mice by using the wild-type
Vb8.2 and three Vb8.2 mutants, bY46A, bY48A, and bE54A.
Bone marrow cells from 5-FU treated TCR Cb and Cd-deficient
mice were transduced with retroviral constructs encoding oneImmunity 31, 60–71, July 17, 2009 ª2009 Elsevier Inc. 63
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Staining of hybridomas expressing mutant versions of the Va14i TCRa chain associated with the wild-type (A) Vb8.2, (B) Vb7, or (C) Vb2 TCRb chains. Staining of
hybridomas expressing alanine substitutions of (D) Vb8.2, (E) Vb7, or (F) Vb2 associated with the wild-type Va14i TCRa chain. Colors and their representations are
as follows: dark blue, CDR1a; magenta, CDR2a; green, CDR3a; light blue, CDR1b; and pink, CDR2b. ‘‘WT’’ represents an unsubstituted Va14i TCRa chain paired
with unsubstituted Vb8.2, Vb7, or Vb2 TCRb chains (wild-type controls). ‘‘Va3.2’’ represents Va14i TCRa chain in which the CDR1a region is swapped for the
Va3.2 CDR1a region and paired with the appropriate TCRb chains (negative controls for TCRa substitutions). Va13 represents Va13-Ja18 TCRa chain paired
with the appropriate TCRb chains (negative controls for the TCRb substitutions). ND, not done. The MFI of tetramer staining for each mutant was determined
for a narrow TCR gate and normalized to wild-type MFI (set as 100%). Data represent the mean + SEM of three independent experiments. Analysis of the
Vb8.2 mutants, with the exception of Y46A and E54A mutants, has been published previously in (Scott-Browne et al., 2007) and is shown for comparison.of the Vb8.2 chains and transferred to sublethally irradiated
RAG1-deficient mice. Four to six weeks after reconstitution,
chimeric mice were sacrificed and analyzed for the presence
of iNKT cells in the thymus by aGC-CD1d tetramer staining.
Although the wild-type Vb8.2 TCRb chain and bE54A mutant
chains restored T cell development (Scott-Browne et al., 2009),
as well as a sizeable iNKT cell population, iNKT cells were unde-
tectable in the chimeric mice expressing the bY46A and bY48A
mutant chains (Figure S3). Comparable results were obtained64 Immunity 31, 60–71, July 17, 2009 ª2009 Elsevier Inc.with conventional TCR transgenic animals generated with the
wild-type Vb8.2 and the bY48A chains (data not shown). These
results suggest that the same contacts between the CDR2b
region of the iNKT TCR are needed for engagement of natural
ligand(s)-mCD1d complex(es) and for positive selection of
iNKT cells.
When paired with the invariant Va14 chain, some Vb chains,
such as Vb6, do not bind the aGC-CD1d tetramer (Figure 1),
nor do they respond to any of the glycolipid antigens that were
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sized that specific CDR2b residues within these Vb chains might
prevent interaction with mCD1d or that the residues that favor
the interaction might be absent. To test this possibility directly,
we decided to swap the entire CDR2b region of Vb8.2 (including
two framework residues T53b and E54b) into the Vb6 TCR chain
(Figure 4A). The Vb6 chain was chosen because (1) it is relatively
similar to Vb8.2 (44% identity; 77% similarity); (2) the Y46b
residue is already present in Vb6, and (3) Va14iVb6 TCRs with
the CDR3b DO-11.10 do not interact with aGC-CD1d tetramers
nor do they recognize any of the ten different iNKT cell antigens
used in this study (Figure 1, Figure 2, and Figure 4B).
The CDR2-modified Vb6 chain was expressed in the TCRab-
hybridoma with the Va14 invariant chain and TCR-expressing
hybridomas were sorted by flow cytometry. The cells were
then stained with aGC-CD1d tetramers. Swapping the Vb6
CDR2 sequence with that of Vb8.2 was sufficient to allow the
TCR to interact with the aGC-CD1d complex (Figure 4B). In addi-
tion, hybridomas expressing Vb8.2- and Vb6-modified iNKT
TCRs responded similarly to APCs presenting aGC, PBS57,
and iGb3 (Figure 4C). We wanted to extend these findings to
another Vb8.2-related Vb chain. The Vb14 CDR2b loop encodes
for two of the three residues (bY46 and bE54) that are important
for the binding of Vb8.2- and Vb7-containing TCRs to the
antigen-CD1d complex (Figure 3). However, an isoleucine
residue is found at position 48 in place of the tyrosine residue
found in Vb8.2 and Vb7 CDR2 loops (Figure S2). Therefore,
we decided to replace the I48 residue by a tyrosine into this
Vb. The mutant TCRb chain was expressed with the invariant
Va14 chain into the 5KC hybridoma; TCR-expressing cells
were sorted and stainedwith the aGC-CD1d tetramer. The single
introduction of a Y residue at position 48 of the CDR2b of the
Vb14 chain was enough to increase the MFI of aGC-CD1d
tetramer binding to this TCR by more than 4-fold compared to
the binding to the wild-type Vb14-containing TCR (Figure S4).
Altogether, these results demonstrate that residues within the
CDR2b loop are necessary and sufficient for dictating iNKT
TCR reactivity with aGC-CD1d complexes.
Next, we tested whether CDR2b residues also influence the
positive selection of iNKT cells. TCRb ‘‘retrogenic’’ mice were
produced with the wild-type Vb6 and the CDR2-modified Vb6
mutant. Bone marrow cells from 5-FU treated TCR Cb-deficient
mice were transduced with either of the two retroviral constructs
and transferred into lethally irradiated CD45.1 congenic mice.
Four to six weeks after reconstitution, chimeric mice were sacri-
ficed and analyzed for the presence of iNKT cells in the thymus.
iNKT cells were not detectable in chimeric mice expressing the
wild-type Vb6 chain (Figures 4D and 4E). By contrast, mice
expressing the CDR2b-modified Vb6 chain developed aGC-
CD1d tetramer+ cells (Figures 4D and 4E). To formally exclude
that the apparent absence of aGC-CD1d tetramer+ cells in
Vb6-expressing retrogenic mice might be due to the inability of
the tetramer to interact with this particular TCR (Figure 4B), we
also measured by quantitative PCR the amount of Va14-Ca
mRNA found within sorted CD45.1 CD8 GFP+ TCRb+ cells
from the thymus of the retrogenic mice (Figure 4F). The results
demonstrated that Va14-Ca mRNA was only significantly de-
tected within retrogenic T cells expressing the CDR2-modified
Vb6 chain but not the wild-type Vb6 chain.Figure 4. CDR2b Swapping Restores CD1d-Glycolipid Recognition
(A) The Vb6 CDR2b was substituted with that of Vb8.2, from positions 46 to 54
(boxed sequence).
(B) Staining of hybridomas expressing the indicated TCRb chain associated
with the Va14i TCRa chain.
(C) Enzyme-linked immunosorbent assay of IL-2 production by hybridomas
stimulated with mCD1d-expressing A20 cells in the presence of aGC (1 mg/
ml), PBS57 (1 mg/ml), or iGb3 (10 mg/ml) or plate-bound anti-CD3 (5 mg/ml)
and anti-CD28 (2 mg/ml) antibodies. Data represent the mean + SEM of three
independent experiments.
(D) TCRb-deficient donor bone marrow cells were infected with retroviruses
encoding the indicated TCRb chain and eGFP as a reporter. Cells were
injected i.v. into sublethally irradiatedCD45.1 congenic recipientmice. Thymo-
cytes were stained 5 weeks after reconstitution. Cells were gated on eGFP+
B220 CD8 F4/80 Gr-1 cells and presented plots are representative of
two independent experiments (three mice/group). Percentage of aGC-CD1d
tetramer-positive TCRb+ cells in the thymus of TCRb retrogenic mice is shown.
(E) Data shown are the mean percentage + SEM of six mice/group. Statistical
significance (p < 0.001) was determined with an unpaired Student’s t test.
(F) Thymocytes from TCRb retrogenic mice were depleted of cells expressing
CD8a and CD45.1 and sorted for eGFP, TCRb, and CD4 expression, and total
RNA was prepared. Amounts of Va14-Ca transcripts were analyzed by quan-
titative PCR. Normalization of the samples was relative to the quantity of Ca
transcripts. Data are representative of two experiments.Immunity 31, 60–71, July 17, 2009 ª2009 Elsevier Inc. 65
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straints imposed by the amino acid composition of the CDR2b
loop play a critical role in the TCRb bias of the selected iNKT
cell repertoire in vivo.
CDR3b Modulates iNKT TCR Affinity
Comparative analysis of TCRb chains in the context of the
DO-11.10 CDR3b revealed that most Vb chains, including Vb6,
did not result in glycolipid-CD1d complex interaction (Figure 1)
and, at least for Vb6, did not drive the development of iNKT cells
in vivo (Figure 4D). However, Vb6-expressing iNKT cells exist
in vivo, albeit at a low frequency, and Vb6-expressing iNKT cell
hybridomas have been described previously (Behar et al.,
1999). One possibility that might reconcile these apparently
contradictory results may lie within the CDR3b amino acid com-
position of the various Vb6+ iNKT TCRs studied. The CDR3b
Figure 5. CDR3b Modulates iNKT TCR Affinity
(A) Sequence of the wild-type Vb8.2, wild-type Vb7, wild-type
Vb6 WT, and CDR2-modified Vb6 CDR3b random constructs.
(B) Staining of hybridomas expressing the indicated CDR3b
random construct associated with the Va14i TCRa chain.
The percentage of aGC-CD1d tetramer-positive cells is
shown. Plots are gated on live eGFP+ cells and are represen-
tative of four independent experiments.
(C) Enzyme-linked immunosorbent assay of IL-2 production
by hybridomas stimulated with the indicated antigen in the
presence of mCD1d-expressing A20 cells. Data shown are
the mean ± SD. One representative experiment out of two is
shown.
amino acid composition can significantly modulate
the overall affinity of the iNKT TCR for the antigen-
CD1d complex (Scott-Browne et al., 2007). Conse-
quently, the amino acid diversity tolerated within
the CDR3b loop might vary depending upon the
Vb used. We tested this hypothesis by using retro-
viruses to generate four CDR3b libraries encoding
the wild-type Vb8.2 chain, the wild-type Vb7 chain,
the wild-type Vb6 chain, or the Vb6 chain with its
CDR2b replaced by the Vb8.2 CDR2b sequence.
Five positions at the tip of the CDR3b loops were
randomized for each of the libraries (Figure 5A)
and were estimated so that between 6,000 and
17,000 different sequences (data not shown) could
be encoded. Retroviruses were prepared and used
for transduction of the Va14i-expressing TCRb-
negative hybridoma. Transduced cells were sorted
for TCRb expression and stained with the aGC-
CD1d tetramer. More than 80% of the CDR3b
sequences in the context of wild-type Vb8.2-
expressing TCRs interacted with the tetramer
(Figure 5B), suggesting that most of these CDR3b
sequences are compatible with aGC-CD1d recog-
nition, in agreement with previous results (Lantz
and Bendelac, 1994; Matsuda et al., 2001).
Only 50%of the TCRs expressing Vb7 and 4%of
the TCRs expressing the wild-type Vb6 libraries in-
teracted with the aGC-CD1d tetramer (Figure 5B).
Remarkably, more than 90% of the TCRs expressing the modi-
fied Vb6 bound the tetramer. Altogether, these results demon-
strate that the CDR3b amino acid composition diversity that is
tolerated by the iNKT TCR and still preserves aGC-CD1d
tetramer recognition varies with Vb usage. However, only a few
wild-type Vb6-containing iNKT TCRs appeared compatible with
aGC-CD1d recognition. To determine the nature of the CDR3b
responsible for this reactivity, we sorted aGC-CD1d tetramer-
positive and -negative cells from the Vb6+ TCR library and ex-
tracted mRNA from each population. After cDNA synthesis, the
Vb6 TCRs were amplified by PCR with appropriate primers,
cloned into the retroviral vector, and sequenced. In addition,
each Vb6 TCR was expressed separately with the invariant
Va14 chain into the 5KC hybridoma and stained with the aGC-
CD1d tetramer. As shown in Table S1, a unique combination of
CDR3b sequences was found within the tetramer-positive66 Immunity 31, 60–71, July 17, 2009 ª2009 Elsevier Inc.
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negative population were more diverse. Analysis of the CDR3b
sequences revealed the I/LXXPL/I motif (in which X represents
any amino acid and slashes separate alternative amino acids
that may occupy a given position) which, in the context of Vb6-
Jb1.1 rearrangement with a fixed CDR3 length, appears to be
required for high binding to the aGC-CD1d tetramer. These
results support the hypothesis that only few wild-type Vb6-con-
taining iNKT TCRs, with specific CDR3b sequences, are in fact
compatible with aGC-CD1d recognition. In striking contrast,
when the Vb6 chain had a modified CDR2b region, greater
than 90% of the CDR3b sequences within the retroviral library
were tolerated and interacted with the aGC-CD1d tetramer
(Figure 5B). Thus, the extent of CDR3b sequence diversity that
is tolerated by iNKT TCRs and still maintains aGC-CD1d
tetramer recognition is a function of the Vb used by the TCR
and, more specifically, is controlled by the particular CDR2b
amino acid composition of this Vb chain.
To test whether the Vb hierarchy previously established by use
of Vb chains with a fixed CDR3b region (Figure 1) could be
extended to include a diverse collection of CDR3bs, we as-
sessed the ability of hybridomas from the various TCR libraries
to respond to other iNKT cell antigens (Figure 5C). In all cases,
the Vb hierarchy remained the same in the context of TCRs
with diverse CDR3bs, with Vb8.2-expressing cells responding
better than Vb7- and Vb6-expressing cells to all glycolipids
tested. These data demonstrate that our previous results with
all Vbs in the context of the fixed CDR3b of DO-11.10 are repro-
ducible even in the context of a diverse unselected repertoire.
Figure 6. Optimal CDR2b and CDR3b Composition Improves iNKT
TCR Affinity for CD1d
‘‘Unloaded’’-CD1d tetramer-positive hybridomas derived from the CDR2-
modified Vb6 chain TCR library were sorted twice and stained with the indi-
cated tetramers. Plots are gated on live eGFP+ cells and are representative
of three independent experiments.Finally, on the basis of the above results, one might predict
that by selecting adequate CDR2b and CDR3b residues, the
affinity of the iNKT TCR for the antigenic-CD1d complex might
be improved. In fact, while controlling for the specificity of the
aGC-CD1d tetramer staining, we realized that a small but repro-
ducible percentage of TCR-expressing hybridomas derived from
the CDR2b-modified Vb6 chain TCR library interacted with the
control CD1d tetramer, which is not ‘‘loaded’’ with any exoge-
nous antigen (Figure 5B). These cells were sorted twice and
subsequently retested for reactivity with the ‘‘unloaded’’ CD1d
tetramer. Although no external antigen was added in the prepa-
ration of the tetramer reagent, it is likely that ‘‘natural’’ lipid(s)
derived from the 293 cells used to produce CD1d monomers
are in fact loaded within the groove of CD1d molecules (Yuan
et al., 2009). As seen in Figure 6, a homogeneous population of
hybridomas expressing TCRs capable of interacting with the
‘‘unloaded’’ mouse CD1d tetramer could clearly be defined.
These results demonstrate that the affinity of the iNKT TCR for
the CD1d-antigenic complex can be improved upon by opti-
mizing the CDR2 and CDR3 loops of the Vb chain. Furthermore,
at an identical amount of TCR expression, the MFI of aGC-CD1d
tetramer staining is higher compared with the MFI of ‘‘unloaded’’
tetramer staining (Figure 6). These results suggest that the
affinity of TCRs selected on the basis of the recognition of an
unknown self-antigen presented by mouse CD1d molecules
can be further improved by the addition of an iNKT cell antigen
such as aGC.
DISCUSSION
Identification of the structural features of antigen recognition by
iNKT cells is critical to understanding this lymphocyte population
and to the design of effective ligands aimed at exploiting iNKT
cell functions. iNKT cells express a semi-invariant TCR, com-
posed of Va24-Ja18 segments paired with Vb11 in humans
and Va14-Ja18 segments paired with a limited set of Vb chains
in mice (Vb8.2, Vb7, and Vb2). The reasons for this Vb usage
bias have remained unclear. We found no evidence that certain
Vb chains are excluded from the iNKT repertoire because
they cannot pair with the Va14 invariant chain, given that the
hybridoma subclones we generated with each of 20 different
Vbs all expressed similar amounts of TCR and appeared stable.
Notably, only 8 of the 20 different Vb segments, when associated
with the Va14 invariant chain, produced a TCR that, at identical
expression, interacted with the aGC-CD1d tetramer. The relative
avidity of these TCRs for the aGC-CD1d complex, as measured
by titration of the tetramer, varied greatly. These results demon-
strate that the Vb composition of the iNKT TCR affects its affinity
for the aGC-CD1d complex and are in good agreement with
previous studies showing that the TCRb chain influences the
avidity of aGC-CD1d binding, with Vb8.2 conferring higher
avidity than Vb7 and than Vb2 (Schumann et al., 2003; Stanic
et al., 2003).
Interestingly, the relative avidities conferred by the different Vb
correlated positively with the frequencywith which the Vb is used
in the natural repertoire. These results suggest the possibility
that a certain affinity threshold of the iNKT TCR for the positively
selecting ligand-CD1d complex might be required for positive
selection of iNKT cells. In this scenario, Vb9-, Vb10-, andImmunity 31, 60–71, July 17, 2009 ª2009 Elsevier Inc. 67
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self-ligand(s)-CD1d complexes that positively select iNKT cells.
One potential problem with such an interpretation is that the
nature of the positively selecting ligand(s) remains uncertain,
and therefore the Vb hierarchy observed for reactivity to the
aGC-CD1d complex might not translate to other antigen-CD1d
complexes. The data presented here suggest that, in general,
iNKT TCRs react with different antigens with a defined hierarchy,
reacting best with CD1d bound to aGC and PBS57, less well
with, for example, CD1d bound to iGb3, and undetectably with
CD1d bound to self ligand(s). Again, in general, the affinity of
iNKT TCRs for a particular ligand, aGC-CD1d, for example, is
controlled by CDR2b and CDR3b, such that iNKT TCRs that
contain Vb8.2 usually react more strongly that those that contain
Vb2 and even more strongly than those containing Vb6. CDR3b
sequences modulate this phenomenon, however, so that a few,
rare CDR3b sequences can compensate the inadequacies of
Vb6 CDR2b and allow recognition. Conversely, a few, rare
CDR3b sequences can interfere with the otherwise excellent
recognition properties of iNKT TCRs containing Vb8.2. Thus
our data suggest that, in general, iNKT TCRs recognize CD1d
bearing different ligands with the same hierarchy of affinities;
such an idea is supported by crystallographic data showing
that the glycolipid ligand is engaged only by the invariant iNKT
TCR a chain (Borg et al., 2007; Pellicci et al., 2009). If this is
true for all ligands, the iNKT TCR b chain can affect the affinity
of the iNKT TCR by affecting its ability to bind CD1d, but can
only affect the specificity of the iNKT TCR if it affects the orienta-
tion of the TCR a chain or if the glycolipid ligand affects the
configuration of the CD1d protein itself.
Analysis of Vb usage by iNKT cells in vivo under conditions in
which CD1d was underexpressed revealed an increased
frequency of Vb7+ iNKT cells, whereas the proportion of Vb8.2+
iNKT cells remained constant (Schumann et al., 2006; Wei
et al., 2006). These results were interpreted as a reflection of
the preferential positive selection of Vb7+ iNKT cells at subop-
timal endogenous ligand concentration and suggested that the
hierarchy of Vb usage for the endogenous positively selecting
ligand(s) is Vb7 > Vb8.2 > Vb2. A similar Vb hierarchy was found
for the response to the self-glycosphingolipid iGb3, and it was
argued that only iNKT cell TCRs composed of Vb8.2, Vb7, or
Vb2 were suitable for positive selection by the iGb3-CD1d
complex (Schumann et al., 2006; Wei et al., 2006). In our
in vitro experiments, we did not find a Vb7 bias in response to
any of the glycolipids that we tested, including iGb3. The reasons
for the discrepancy between the in vivo and in vitro results are
currently unclear. On the one hand, it is possible that particular
CDR3b sequences are used by Vb7+ iNKT cells for the recogni-
tion of iGb3 in vivo in a way that our CDR3b library would not
reveal, perhaps because of the fixed CDR3b length and/or Jb
that we used. On the other hand, the precise nature of the
ligand(s) involved in positively selecting the iNKT cell repertoire
remains unknown, and the role of iGb3 in this process is currently
controversial (Christiansen et al., 2008; Li et al., 2008; Li et al.,
2009; Porubsky et al., 2007; Speak et al., 2007). Thus, the panel
of antigens that we tested in vitro might not be representative of
the ligand(s) involved in positive selection. Although such apossi-
bility cannot be formally excluded, it would imply that recognition
of the positively selecting ‘‘self’’ by the iNKT TCR is somehow68 Immunity 31, 60–71, July 17, 2009 ª2009 Elsevier Inc.different from the recognition of aGC and the other glycolipids
tested. Unfortunately, we cannot further test this hypothesis
with our current TCR mutants because the hybridomas do not
show substantial autoreactive response in the presence of
thymocytes or bone-marrow-derived dendritic cells (data not
shown). Nevertheless, we agreewith the earlier study suggesting
that the iNKT TCR repertoire directed at glycolipid-CD1d
complexes could indeed be potentially larger than the actual
natural repertoire of iNKT cells (Wei et al., 2006). It is possible
that the overall affinity of the iNKT TCR for the glycolipid(s)-
CD1d complex responsible for the positive selection of the cells,
rather than the specific nature of a particular ligand, might be
responsible for this restriction in repertoire diversity.
Mutational analysis of three mouse iNKT TCRs with the
invariant Va14 chain associated with Vb8.2, Vb7, or Vb2 demon-
strated that the ‘‘energetic hot spot’’ of the TCR on the aGC-
CD1d complex remains largely similar, regardless of the Vb chain
used. These results are substantiated by the recent analysis of
the crystal structures of twomouse iNKT TCRs, containing either
Vb8.2 or Vb7, in complex with aGC-CD1d (Pellicci et al., 2009). In
both cases, the invariant TCRa chain dominates the interaction
with both the glycolipid and mouse CD1d, whereas the role of
the TCRb chain ismostly restricted to theCDR2b loop interacting
with the a1 helix of CD1d. Importantly, the CDR2b residues that
mediate these interactions with the a1 helix of CD1d, namely Y46
and Y48, are conserved between human Vb11 andmouse Vb8.2.
This suggest that the amino acid sequence of the CDR2b loop is
likely to be critically important in determining which Vb chain,
when associated with Va14, can interact with CD1d molecules.
Similarly, analysis of mice transgenic for TCRb chains usually
not found in the iNKT cell repertoire demonstrated that they do
not support positive selection of iNKT cells in vivo (Dao et al.,
2004; Ohteki and MacDonald, 1996). Furthermore, the crystal
structure of the Vb7+ iNKT TCR indicates that the Y48 residue,
conserved between Vb8.2 and Vb7, makes similar contacts
with CD1d. Because the Vb7 chain leans more toward the
CD1d molecule than the Vb8.2 chain, further contacts mediated
by the CDR2b S54 and the CDR1b E28 residues with the CD1d
molecules tend to compensate for the absence of the Y46
residue in the CDR2b loop of Vb7 (Pellicci et al., 2009). Two
CDR1b residues (Y30 and W32) in Vb2-containing iNKT TCRs
are also involved for the binding to the aGC-CD1d complex.
These results suggest that, like Vb7, the relative juxta-positioning
of the Vb2 and Va14 domainsmight position the Vb2 chain closer
to the CD1dmolecule, thereby allowing for a greater contribution
of the Vb2 CDR1b loop to interact with CD1d. Moreover,
aromatic residues are known to participate in protein-protein
interactions and the bulky aromatics of Y30b andW32b are likely
to assist in bridging any potential gap between the iNKT TCR and
CD1d.
With the help of retroviral libraries coding for various Vb chains
randomized at five CDR3b positions, we were able to create an
unselected iNKT cell repertoire in vitro. TCRs expressed by
aGC-reactive iNKT cells are known to have polyclonal CDR3b
sequences, and it has been suggested that such diversity might
allow for discrimination between different glycolipid antigens
loaded on CD1d molecules (Godfrey et al., 2005; Kinjo et al.,
2005). Despite this CDR3b diversity, individual iNKT TCRs react
similarly to many glycolipid-CD1d complexes and the role of the
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(Scott-Browne et al., 2007). We now show that the extent of
CDR3b sequence diversity that is tolerated by iNKT TCRs and
that still maintains aGC-CD1d tetramer recognition is a function
of the Vb used by the TCR and, more specifically, is controlled by
the unique CDR2b amino acid composition of this Vb chain. This
suggest that TCRs with Vb chains that have CDR2b loops that
allow appropriate interactions with CD1d probably reach suffi-
cient affinity for the positively selecting ligand(s)-CD1d complex
so that little to no energy is required from the CDR3b loop. As
a consequence, most CDR3b loops, but not all, are tolerated
and allow recognition of the antigen-CD1d complex. Some
CDR3b loops may impede, rather than enhance, antigen recog-
nition, as demonstrated in an earlier study of human iNKT TCR
binding (Kjer-Nielsen et al., 2006). Overall, when a Vb ideally
suited to interact with CD1d is used, most CDR3b sequences
may be positively selected in the iNKT cell repertoire. By
contrast, for Vb chains with a CDR2b loop that contributes to
fewer interactions with CD1d, specific CDR3b sequences are
necessary to compensate for the lack of energy provided to
the interaction. This is perhaps best exemplified by the selection
of a particular CDR3bmotif that allows some Vb6 TCRs to recog-
nize CD1d and ligands. Thus, relatively few TCRs using these
particular Vbs (such as Vb6) would then be expected in the
natural iNKT cell repertoire; such a result is consistent with our
observations. These results suggest a functional collaboration
between the CDR2b and CDR3b loops, where the iNKT cell
repertoire might be represented as a ‘‘sliding scale’’ with the
affinity of the TCR determined by a hierarchy of Vb chains and
modulated by the CDR3b composition for this particular Vb
chain. Hence, we propose that the inherent CD1d reactivity of
a given Vb chain determines its relative position in the Vb hier-
archy, whereas the CDR3b sequence defines the placement of
an individual TCR within the overlapping hierarchy.
What then, are the functional consequences of restricting the
iNKT cell repertoire to a limited number of Vb domains? For
‘‘conventional’’ T cells that recognize highly polymorphic MHC
molecules, developing a broad Va and Vb repertoire of TCRs
allows the immune system to respond to the array of potential
foreign peptides. Thus, restricting the TCRb diversity among
the iNKT cell population would potentially exclude cells capable
of recognizing some glycolipid antigens. Indeed, we and others
(Wei et al., 2006) have observed that some TCRs capable of
aGC-CD1d recognition are excluded from the iNKT cell reper-
toire. One might expect, a priori, that a less diverse iNKT cell
population would impair the host’s ability to recognize foreign
glycolipid antigens. Alternatively, we propose that restricting
the TCRb repertoire in fact promotes a ‘‘functionally diverse’’
iNKT cell population. Using mutational analyses, supported by
crystallographic studies (Borg et al., 2007; Pellicci et al., 2009),
we observed that the iNKT TCR uses primarily germline-
encoded residues to recognize CD1d presenting diverse glyco-
lipids (Borg et al., 2007; Scott-Browne et al., 2007). On the basis
of these data, we proposed that the iNKT TCR functions as
a pattern recognition receptor, in which diverse antigens are
recognized with a conserved TCR recognition strategy (Scott-
Browne et al., 2007). The three NKT TCR-CD1d structures
currently available are broadly consistent with this proposition.
Although thymic selection restricts the iNKT population to onlya few Vb, the majority of cells in this repertoire is capable of
recognizing a wide array of potential antigens. Using this mech-
anism during development excludes iNKT cells, which may only
recognize the highest affinity antigens. Thus, seemingly restrict-
ing the iNKT cell repertoire promotes and magnifies efficient
recognition of many potential pathogens.
EXPERIMENTAL PROCEDURES
Reagents
a-galactosylceramide (aGC) and isoglobotrihexosylceramide (iGb3) were
purchased from Alexis Biochemicals. PBS57, a modified version of aGC
with a hydroxyl group at the C6 position of galactose (Liu et al., 2006), was
kindly provided by P. Savage (Brigham Young University, Provo, Utah),
whereas the a-linked galacturonic acid containing GSL-1’ antigen (Kinjo
et al., 2005) was obtained from the National Institutes of Health core facility.
Modified versions of aGC at the 30 and 40 hydroxyl groups of galactose,
(3 dOH aGC, 4 dOH aGC) and a-glucosylceramide (a-GluCer) compounds
were synthesized by A. Howell (University of Connecticut, Storrs, Connecticut)
and have been described previously (Wun et al., 2008). Nonglycosidic
compoundswith clipped versions of the head group in which the alcohol moie-
ties at C(5) and C(6) of the galactose were absent have been described previ-
ously (Silk et al., 2008).
TCRab Constructs and Retroviral Plasmids
Wild-type and mutant TCRa chains were generated as previously described
(Scott-Browne et al., 2007). Wild-type and mutant TCRb chains were con-
structed by PCR from C57BL/6 thymus-derived cDNA, or alternatively from
plasmid templates, with overlapping primers and cloned into engineered
restriction sites. TCRb constructs were cloned into mouse stem cell virus-
based plasmids with an internal ribosome entry site (IRES) plus sequence
encoding for the human nerve growth factor receptor as a reporter (kindly
provided by S. Reiner, University of Pennsylvania).
Cell Lines and Retroviral Packaging
Wild-type or mutant TCRb constructs were expressed together with wild-type
or mutant Va14i TCRa constructs by retroviral transduction of 5KC-78.3.20,
a hybridoma selected for loss of both TCRa and TCRb chains (White et al.,
1993). Retroviral plasmids were transfected into Phoenix cells together with
the pCLEco accessory plasmid with Lipofectamine 2000 (Invitrogen) accord-
ing to the manufacturer’s specifications. Retrovirus-containing supernatants
were harvested 48 hr after transfection, centrifuged, and filtered for removal
of debris. Hybridomas were ‘‘spin-infected’’ at 3300 3 g for 90 min at 37C
in retrovirus-containing supernatants supplemented with polybrene (8 mg/ml).
Hybridomas were then sorted on a MoFlo cell sorter (Dakocytomation) on the
basis of retroviral reporter and TCRb expression.
Tetramer Staining
Biotinylated recombinant mouse CD1d protein, provided by the National Insti-
tutes of Health Tetramer core facility, was incubated overnight with aGC in
a solution of 0.05% (vol/vol) Tween 20 in PBS and then phycoerythrin-conju-
gated streptavidin was added. Alternatively, the ‘‘unloaded’’ tetramer was
prepared identically without the addition of the antigen aGC. Hybridomas
were stained for 45 min at 25C with the indicated tetramer plus antibody to
TCRb (anti-TCRb; H57-597; eBiosciences), and cells were analyzed on
a FACSCalibur or FACScan flow cytometer (BD Biosciences). Data were
analyzed with FlowJo software (Treestar).
Hybridoma Stimulation
A total of 53104hybridomaswere cultured for 20hrwith 53104mCD1d-trans-
fected A20 cells, plus the indicated antigens, in complete RPMI medium con-
taining 10% (vol/vol) FCS. Hybridoma responses were measured by an IL-2
enzyme-linked immunosorbent assay in accordance with standard protocols.
Ex Vivo NKT Cell Analysis
Thymocytes from C57BL/6 mice were subjected to depletion by magnetic-
activated cell separation with anti-CD8a beads (Miltenyi Biotec) and culturedImmunity 31, 60–71, July 17, 2009 ª2009 Elsevier Inc. 69
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R&D Systems). Cells were stained for 45 min at 25C with mouse CD1d
tetramer loaded with aGC plus antibody to TCRb. aGC-CD1d tetramer+
TCRb+ cells were sorted with a MoFlo cell sorter and then cultured for another
4 days in complete RPMI medium containing 10% (vol/vol) FCS and IL-15
(50 ng/ml). Cells were stained with mouse CD1d tetramer loaded with aGC
plus antibody to TCRb for purity control or with antibodies to Vb2, Vb3, Vb4,
Vb6, Vb7, Vb8.1, Vb8.2, Vb8.3, Vb9, Vb10, Vb12, and Vb14. Vb8.1 relative
usage was determined by differential staining between antibodies to Vb8.1/
8.2 (clone KJ16) and to Vb8.2 (clone F23.2).
TCRb ‘‘Retrogenic’’ Mice
TCRb constructs were cloned into mouse stem cell virus-based plasmids with
an IRES and sequence encoding green fluorescent protein (eGFP) as
a reporter. Retroviruses were produced as described above. Bone marrow
cells from five fluorouracyl-treated TCRb/d-deficient or TCRb-deficient donor
mice (0.15 mg/g weight) were harvested and cultured for 4 days in DMEM
conditioned medium containing IL-3, IL-6, and SCF. Cells were ‘‘spin-
infected’’ on day 1, 2, and 3 after collection and injected on day 4 into suble-
thally irradiated CD45.1 congenic recipient mice (900 rads) or alternatively
RAG1-deficient mice (400 rads). Five to six weeks after reconstitution,
chimeric mice were sacrificed and thymocytes were stained for 45 min at
4C with phycoerythrin-conjugated aGC-CD1d tetramer, PerCP-conjugated
anti-TCRb mAb, allophycocyanin-conjugated anti-CD45.1 mAb, and Pacific
Blue-conjugated anti-B220, anti-CD8a, anti-F4/80, and anti-Gr1 mAbs. Cells
were acquired on a LSRII flow cytometer (BD Biosciences), and data were
analyzed with FlowJo software. All procedures were approved by the institu-
tional animal care and use committee.
Quantitative RT-PCR
Thymocytes from TCRb retrogenic mice were stained with biotin-conjugated
antibodies to CD8a and CD45.1, were subjected to depletion by magnetic-
activated cell separation with anti-biotin beads (Miltenyi Biotec), and stained
with antibodies to CD4 and TCRb. eGFP+ TCRb+ CD4+ cells were sorted
with a MoFlo cell sorter, and total RNA was prepared with TRIzol solution (In-
vitrogen) in accordance with the manufacturer’s protocol. Reverse transcrip-
tion was carried out with the SuperScript III kit (Invitrogen), and the amount
of amplicon generated during PCR was monitored with a DNA engine Opticon
2 apparatus (Bio-Rad) with gene-specific primers and probes and the Platinum
Quantitative PCR SuperMix UDG (Invitrogen). Primers and probes have been
described previously (Gapin et al., 2001).
CDR3b Libraries
Wild-type Vb8.2, wild-type Vb7, wild-type Vb6, and CDR2-modified Vb6 CDR3b
randomconstructsweregeneratedbyPCRwith forwardprimers specificof each
Vb chain and the reverse primer 50-TCT CAGATC TTC TAC AAC TGT GAG TCT
GGTTCCTTTACCAAAGAAGACTTCSNNSNNSNNSNNSNNGGATCCGCT
GGC ACA-30 (Integrated DNA Technologies). We obtained full-length TCRb
constructsby overlappingPCRand cloned them into engineered restriction sites
in the pMSCVpuro vector (Clontech). We estimated the size of the libraries to be
8,000, 6,000, 6,500, and 17,000 sequences for wild-type Vb8.2, wild-type Vb7,
wild-type Vb6, andCDR2-modifiedVb6, respectively.Wepackaged retroviruses
as described above and used them to transduce the TCR-negative hybridoma
5KC-78.3.20, together with the Va14i TCRa chain, at a low infection rate (<1%)
to minimize multiple retroviruses entering a single cell. TCR-positive cells were
enriched by addition of puromycin (1 mg/ml) into the culture media and hybrid-
omas were subsequently sorted for TCR expression.
SUPPLEMENTAL DATA
Supplemental Data include four figures and one table and can be found
with this article online at http://www.cell.com/immunity/supplemental/
S1074-7613(09)00277-5.
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